CerenovusSummer 2026Active☆Watch⊞Compare

Cerenovus is one of 2067 AI / ML companies tracked from San Francisco, CA, USA, on record since 2026. By capital raised it ranks mid-pack (ahead of 62% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst”

Aggregate company knowledge and make inferences

Cerenovus is a company brain. We aggregate every kind of file a company produces — documents, PDFs, emails, Slack messages, spreadsheets, meeting notes — and convert them into a single markdown knowledge graph with native AI-agent integration. A company's information becomes uniformly readable both by humans and by the AI agents working inside the graph. On top of that foundation, Cerenovus maps the company as a system, drawing connections between the people, processes, and tools that make up real workflows. From that systems map, it infers where operations are inefficient and how to improve them. In practice, this tool will help executives make better decisions. Whenever a leader has to act on a question — how to restructure a team, whether to keep a vendor, or where handoffs between teams are breaking down — Cerenovus will give them an evidence-backed answer in minutes rather than weeks. Today, that work is done by consultants, by internal analysts, or by the executive asking around informally. Each of those approaches is slow, partial, and goes stale the moment it is delivered. Cerenovus produces the same answers faster, at a fraction of the cost, and keeps them live as the company evolves.

As reported in public records reported — not modeled.

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

No round amounts on record to chart.

No staged rounds to sequence.

Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Benchmarked against 2067 companies in AI / ML. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Raised more than 62% of sector peers (real $). Modeled value above 62% of peers (estimate).

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Cerenovus is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

See where Cerenovus sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

If you work at Cerenovus, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.